New CFO to Drive Commercial Growth
Swedish life science company PeptiSystems has appointed Ida Nordberg as Chief Financial Officer (CFO). The appointment marks another milestone in the company’s development and further strengthens the organization as it enters its next phase of commercialization and international expansion
Ida Nordberg, who assumed the role of CFO at Uppsala-based PeptiSystems AB in early June, brings more than 15 years of experience in finance positions within the life science industry. Most recently, she worked at Oncopeptides, having previously held roles at GE Healthcare and C-RAD. Throughout her career, she has built extensive expertise in financial management, financial reporting, and business partnering in international organizations.
With Nordberg’s appointment, PeptiSystems is taking the next step in its corporate development while reinforcing the organization for the upcoming phase of commercialization and international expansion.
Founded in 2014, PeptiSystems is developing a new generation of flow-through instruments for peptide and oligonucleotide therapeutics synthesis.
Bayer AG
Wuxi AppTec
bioRN Life Science Cluster